123 related articles for article (PubMed ID: 2906459)
1. Penetration of roxatidine into the cerebrospinal fluid.
Tryba M; Kurz-Muller K
Scand J Gastroenterol Suppl; 1988; 146():153-8. PubMed ID: 2906459
[TBL] [Abstract][Full Text] [Related]
2. The pharmacodynamics and pharmacokinetics of multiple doses of the new H2-receptor antagonist, roxatidine acetate, in healthy men.
Lassman HB; Ho I; Puri SK; Sabo R; Scheffler MR
Drugs; 1988; 35 Suppl 3():53-64. PubMed ID: 2905250
[TBL] [Abstract][Full Text] [Related]
3. [Plasma pharmacokinetics of roxatidine in the healthy man: correlation with gastric antisecretory effect].
Chen WW; Kolsky H; Lewin MJ; Bonfils S
Gastroenterol Clin Biol; 1990; 14(4):342-6. PubMed ID: 1972124
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of roxatidine acetate in patients with chronic liver disease.
Tsutsumi M; Ueshima Y; Takase S
J Gastroenterol Hepatol; 2001 Aug; 16(8):910-5. PubMed ID: 11555106
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of the H(2) blocker roxatidine acetate hydrochloride in pediatric patients, in comparison with healthy adult volunteers.
Nakamura H; Kawashima H; Azuma R; Sato I; Nagao K; Miyazawa K
Drug Metab Pharmacokinet; 2012; 27(4):422-9. PubMed ID: 22293541
[TBL] [Abstract][Full Text] [Related]
6. Roxatidine acetate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic potential in peptic ulcer disease and related disorders.
Murdoch D; McTavish D
Drugs; 1991 Aug; 42(2):240-60. PubMed ID: 1717223
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of roxatidine in healthy volunteers.
Collins JD; Pidgen AW
Drugs; 1988; 35 Suppl 3():41-7. PubMed ID: 2905248
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of histamine (H2)-receptor antagonists, including roxatidine, in chronic renal failure.
Lameire N; Rosenkranz B; Brockmeier D
Scand J Gastroenterol Suppl; 1988; 146():100-10. PubMed ID: 2906455
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of roxatidine acetate. Evidence from pharmacodynamic and clinical trials.
Merki HS; Bender W; Labs R
J Clin Gastroenterol; 1989; 11 Suppl 1():S20-3; discussion S24. PubMed ID: 2572621
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and pharmacodynamics of roxatidine in patients with renal insufficiency.
Gladziwa U; Wagner S; Sieberth HG; Klotz U
Br J Clin Pharmacol; 1995 Feb; 39(2):161-7. PubMed ID: 7742154
[TBL] [Abstract][Full Text] [Related]
11. Effects of roxatidine acetate on 24-hour gastric acidity. Early evening versus bedtime administration in healthy subjects.
Hemery P; Congard P; Galmiche JP; Bonfils S
Drugs; 1988; 35 Suppl 3():76-81. PubMed ID: 2905253
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic characteristics of roxatidine.
Bender W; Brockmeier D
J Clin Gastroenterol; 1989; 11 Suppl 1():S6-19. PubMed ID: 2572622
[TBL] [Abstract][Full Text] [Related]
13. Lack of effect of multiple dose sucralfate on the pharmacokinetics of of roxatidine acetate.
Seibert-Grafe M; Pidgen A
Eur J Clin Pharmacol; 1991; 40(6):637-8. PubMed ID: 1679394
[No Abstract] [Full Text] [Related]
14. A pharmacokinetic study of roxatidine acetate in chronic renal failure.
Lameire N; Rosenkranz B; Maass L; Brockmeier D
Drugs; 1988; 35 Suppl 3():48-52. PubMed ID: 2905249
[TBL] [Abstract][Full Text] [Related]
15. Effects of changing the type of H2-blocker in the treatment of H2-blocker-resistant ulcers: comparison of roxatidine acetate hydrochloride and other H2-blockers.
Yasutake K; Amano M; Mizokami Y; Kubota S; Fukumoto H; Imamura Y; Yokoya H; Irie K
J Int Med Res; 1998; 26(1):25-36. PubMed ID: 9513074
[TBL] [Abstract][Full Text] [Related]
16. Biopharmaceutical characterization of oral controlled/modified-release drug products. In vitro/in vivo correlation of roxatidine.
Frick A; Möller H; Wirbitzki E
Eur J Pharm Biopharm; 1998 Nov; 46(3):313-9. PubMed ID: 9885304
[TBL] [Abstract][Full Text] [Related]
17. Comparative pharmacology of histamine H2-receptor antagonists.
Sewing KF; Beil W; Hannemann H
Drugs; 1988; 35 Suppl 3():25-9. PubMed ID: 2905246
[TBL] [Abstract][Full Text] [Related]
18. The effects of roxatidine acetate (HOE-760) on 24-hour intragastric acidity in healthy volunteers: comparison with ranitidine and placebo.
Merki HS; Witzel L; Kaufmann D; Kempf M; Müssig V; Neumann J; Scheurle E; Röhmel J; Walt RP
Aliment Pharmacol Ther; 1988 Feb; 2(1):73-81. PubMed ID: 2908751
[TBL] [Abstract][Full Text] [Related]
19. A review of the animal pharmacology of roxatidine acetate.
Scholtholt J; Bickel M; Herling AW
Drugs; 1988; 35 Suppl 3():30-40. PubMed ID: 2905247
[TBL] [Abstract][Full Text] [Related]
20. [The effect of oral administration of roxatidine acetate hydrochloride 3 hours prior to the operation on pH and volume of gastric juice].
Kojima A; Andoh K; Shima T; Koga Y; Hashimoto Y
Masui; 1991 Mar; 40(3):451-3. PubMed ID: 1677048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
